186 related articles for article (PubMed ID: 31332161)
1. A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors.
Orienti I; Francescangeli F; De Angelis ML; Fecchi K; Bongiorno-Borbone L; Signore M; Peschiaroli A; Boe A; Bruselles A; Costantino A; Eramo A; Salvati V; Sette G; Contavalli P; Zolla L; Oki T; Kitamura T; Spada M; Giuliani A; Baiocchi M; La Torre F; Melino G; Tartaglia M; De Maria R; Zeuner A
Cell Death Dis; 2019 Jul; 10(7):529. PubMed ID: 31332161
[TBL] [Abstract][Full Text] [Related]
2. A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells.
Orienti I; Salvati V; Sette G; Zucchetti M; Bongiorno-Borbone L; Peschiaroli A; Zolla L; Francescangeli F; Ferrari M; Matteo C; Bello E; Di Virgilio A; Falchi M; De Angelis ML; Baiocchi M; Melino G; De Maria R; Zeuner A; Eramo A
J Exp Clin Cancer Res; 2019 Aug; 38(1):373. PubMed ID: 31439019
[TBL] [Abstract][Full Text] [Related]
3. p38MAPK-Dependent sensitivity of Ewing's sarcoma family of tumors to fenretinide-induced cell death.
Myatt SS; Redfern CP; Burchill SA
Clin Cancer Res; 2005 Apr; 11(8):3136-48. PubMed ID: 15837770
[TBL] [Abstract][Full Text] [Related]
4. Fenretinide: a novel treatment for endometrial cancer.
Mittal N; Malpani S; Dyson M; Ono M; Coon JS; Kim JJ; Schink JC; Bulun SE; Pavone ME
PLoS One; 2014; 9(10):e110410. PubMed ID: 25340777
[TBL] [Abstract][Full Text] [Related]
5. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity.
Myatt SS; Burchill SA
Oncogene; 2008 Feb; 27(7):985-96. PubMed ID: 17700534
[TBL] [Abstract][Full Text] [Related]
6. The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response.
Pagnan G; Di Paolo D; Carosio R; Pastorino F; Marimpietri D; Brignole C; Pezzolo A; Loi M; Galietta LJ; Piccardi F; Cilli M; Nico B; Ribatti D; Pistoia V; Ponzoni M
Clin Cancer Res; 2009 Feb; 15(4):1199-209. PubMed ID: 19228726
[TBL] [Abstract][Full Text] [Related]
7. Anticancer effects of fenretinide in human medulloblastoma.
Damodar Reddy C; Guttapalli A; Adamson PC; Vemuri MC; O'Rourke D; Sutton LN; Phillips PC
Cancer Lett; 2006 Jan; 231(2):262-9. PubMed ID: 16399227
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor activity of fenretinide complexed with human serum albumin in lung cancer xenograft mouse model.
Durante S; Orienti I; Teti G; Salvatore V; Focaroli S; Tesei A; Pignatta S; Falconi M
Oncotarget; 2014 Jul; 5(13):4811-20. PubMed ID: 25015569
[TBL] [Abstract][Full Text] [Related]
9. Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.
Bassani B; Bartolini D; Pagani A; Principi E; Zollo M; Noonan DM; Albini A; Bruno A
PLoS One; 2016; 11(7):e0154111. PubMed ID: 27367907
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide in glioma cells.
Saitoh Y; Goto T; Puduvalli VK; Murakami M; Kochi M; Levin VA; Kyritsis AP; Ushio Y
Int J Oncol; 1999 Sep; 15(3):499-504. PubMed ID: 10427131
[TBL] [Abstract][Full Text] [Related]
11. Methylselenol, a selenium metabolite, modulates p53 pathway and inhibits the growth of colon cancer xenografts in Balb/c mice.
Zeng H; Cheng WH; Johnson LK
J Nutr Biochem; 2013 May; 24(5):776-80. PubMed ID: 22841391
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway- and microtubule-targeting inhibitors.
Skobeleva N; Menon S; Weber L; Golemis EA; Khazak V
Mol Cancer Ther; 2007 Mar; 6(3):898-906. PubMed ID: 17363484
[TBL] [Abstract][Full Text] [Related]
13. Novel Indole-based Tambjamine-Analogues Induce Apoptotic Lung Cancer Cell Death through p38 Mitogen-Activated Protein Kinase Activation.
Manuel-Manresa P; Korrodi-Gregório L; Hernando E; Villanueva A; Martínez-García D; Rodilla AM; Ramos R; Fardilha M; Moya J; Quesada R; Soto-Cerrato V; Pérez-Tomás R
Mol Cancer Ther; 2017 Jul; 16(7):1224-1235. PubMed ID: 28396364
[TBL] [Abstract][Full Text] [Related]
14. P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models.
Lopez-Barcons L; Maurer BJ; Kang MH; Reynolds CP
Int J Cancer; 2017 Jul; 141(2):405-413. PubMed ID: 28340497
[TBL] [Abstract][Full Text] [Related]
15. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
16. KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.
Chattopadhyay N; Berger AJ; Koenig E; Bannerman B; Garnsey J; Bernard H; Hales P; Maldonado Lopez A; Yang Y; Donelan J; Jordan K; Tirrell S; Stringer B; Xia C; Hather G; Galvin K; Manfredi M; Rhodes N; Amidon B
PLoS One; 2015; 10(12):e0144825. PubMed ID: 26709701
[TBL] [Abstract][Full Text] [Related]
17. Fenretinide induces sustained-activation of JNK/p38 MAPK and apoptosis in a reactive oxygen species-dependent manner in neuroblastoma cells.
Osone S; Hosoi H; Kuwahara Y; Matsumoto Y; Iehara T; Sugimoto T
Int J Cancer; 2004 Nov; 112(2):219-24. PubMed ID: 15352033
[TBL] [Abstract][Full Text] [Related]
18. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
19. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling.
Liu RX; Ma Y; Hu XL; Ren WY; Liao YP; Wang H; Zhu JH; Wu K; He BC; Sun WJ
Int J Oncol; 2018 Nov; 53(5):2091-2101. PubMed ID: 30132514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
